Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 127-07-1
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Inhibiting ribonucleotide reductase activity, Hydroxyurea (CAS 127-07-1) suppresses de novo dNTP synthesis, inducing S-phase arrest and apoptosis in CML lymphocytes while potentiating radiosensitivity in pancreatic adenocarcinoma cells through reactive nitrogen species release.
Hydroxyurea (CAS 127-07-1) inhibits ribonucleotide reductase to disrupt DNA synthesis, making it a cornerstone in chemotherapy for chronic myeloid leukemia and ovarian cancer. It elevates fetal hemoglobin, reducing sickle cell crises. Researchers exploit its mutagenic properties to model genetic disorders. This compound also enhances antiretroviral efficacy in HIV therapy. Topically, it treats psoriasis and actinic keratosis by accelerating skin cell turnover.
|
GHS Pictogram :
|
GHS No : GHS08
|
|
Signal Word : Danger
|
UN#: 3077
|
|
Class : 9
|
Packing Group : Ⅲ
|
|
Hazard Statements : H340-H361
|
|
|
Precautionary Statements : P280-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: